Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Leucovorin × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 35 Pancreatic Neoplasms 15 Stomach Neoplasms 14 Colonic Neoplasms 10 Rectal Neoplasms 9 Neoplasm Metastasis 9 Esophageal Neoplasms 8 Adenocarcinoma Of Esophagus 8 Neoplasms 7 Cholangiocarcinoma 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 7 Biliary Tract Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia 2 Gallbladder Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Carcinoma, Renal Cell 2

Interventions

lutetium Lu 177 dotatate 3 pasireotide 2 Octreotide 2 lanreotide 1 copper dotatate CU-64 1 abemaciclib 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Lutetium-177 1 Lutetium 1 Everolimus 1 E-7386 1 Cryotherapy 1 Acupuncture Therapy 1 Acupressure 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡